JP2024522990A5 - - Google Patents
Info
- Publication number
- JP2024522990A5 JP2024522990A5 JP2023574150A JP2023574150A JP2024522990A5 JP 2024522990 A5 JP2024522990 A5 JP 2024522990A5 JP 2023574150 A JP2023574150 A JP 2023574150A JP 2023574150 A JP2023574150 A JP 2023574150A JP 2024522990 A5 JP2024522990 A5 JP 2024522990A5
- Authority
- JP
- Japan
- Prior art keywords
- mixtures
- tautomers
- item
- enantiomers
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195930P | 2021-06-02 | 2021-06-02 | |
| US63/195,930 | 2021-06-02 | ||
| US202163275113P | 2021-11-03 | 2021-11-03 | |
| US63/275,113 | 2021-11-03 | ||
| PCT/US2022/031815 WO2022256434A1 (en) | 2021-06-02 | 2022-06-01 | Protease inhibitors as antivirals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522990A JP2024522990A (ja) | 2024-06-25 |
| JP2024522990A5 true JP2024522990A5 (https=) | 2025-06-10 |
Family
ID=82321542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574150A Pending JP2024522990A (ja) | 2021-06-02 | 2022-06-01 | 抗ウイルス薬としてのプロテアーゼ阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11753373B2 (https=) |
| EP (1) | EP4347034A1 (https=) |
| JP (1) | JP2024522990A (https=) |
| KR (1) | KR20240057384A (https=) |
| AU (1) | AU2022283816A1 (https=) |
| BR (1) | BR112023025358A2 (https=) |
| CA (1) | CA3220847A1 (https=) |
| IL (1) | IL308694A (https=) |
| MX (1) | MX2023014307A (https=) |
| TW (1) | TW202313567A (https=) |
| WO (1) | WO2022256434A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220033383A1 (en) * | 2020-07-20 | 2022-02-03 | Enanta Pharmaceuticals, Inc. | Functionalized peptides as antiviral agents |
| KR20230124583A (ko) | 2020-11-23 | 2023-08-25 | 이난타 파마슈티칼스, 인코포레이티드 | 신규한 스피로피롤리딘 유래 항바이러스제 |
| US12540141B2 (en) | 2020-11-23 | 2026-02-03 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CA3200437A1 (en) * | 2020-12-01 | 2022-06-09 | Arun K. Ghosh | Compounds for the treatment of sars |
| US12398147B2 (en) | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| WO2022256434A1 (en) | 2021-06-02 | 2022-12-08 | ACEA Therapeutics, Inc. | Protease inhibitors as antivirals |
| US12479854B2 (en) | 2021-07-29 | 2025-11-25 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CN118302421A (zh) * | 2021-11-26 | 2024-07-05 | 海南先声药业有限公司 | 一种吡咯烷类抗病毒化合物 |
| US12145941B2 (en) | 2021-12-08 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Heterocyclic antiviral agents |
| TW202334123A (zh) * | 2021-12-31 | 2023-09-01 | 大陸商蘇州愛科百發生物醫藥技術有限公司 | 用於預防和治療冠狀病毒感染的化合物及其偶聯物和方法 |
| CN118451090A (zh) * | 2022-01-13 | 2024-08-06 | 海南先声药业有限公司 | 一种酰胺类抗病毒化合物 |
| WO2023196307A1 (en) | 2022-04-05 | 2023-10-12 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| CN116535460A (zh) * | 2023-04-28 | 2023-08-04 | 中国人民解放军军事科学院军事医学研究院 | 一类含硫拟肽类化合物及其制备方法和用途 |
| WO2024237816A1 (ru) * | 2023-05-12 | 2024-11-21 | Общество С Ограниченной Ответственностью "Промомед Рус" | Новые производные азабициклогексана |
| CN119306790A (zh) * | 2023-07-13 | 2025-01-14 | 深圳市塔吉瑞生物医药有限公司 | 酰胺衍生物及其组合物及用途 |
| EP4686470A1 (en) | 2024-08-01 | 2026-02-04 | Ospedale San Raffaele S.r.l. | Macrocyclic peptidomimetics as antiviral agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1704142A4 (en) * | 2003-12-31 | 2008-08-20 | Taigen Biotechnology Co Ltd | PROTEASE INHIBITORS |
| WO2005113580A1 (en) * | 2004-05-21 | 2005-12-01 | Pfizer Inc. | Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| WO2006061714A2 (en) * | 2004-12-09 | 2006-06-15 | Pfizer Inc. | Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| CN110818691A (zh) | 2018-08-09 | 2020-02-21 | 中国科学院上海药物研究所 | 酮酰胺类化合物及其制备方法、药物组合物和用途 |
| CN113939267B (zh) | 2019-06-05 | 2025-11-11 | 法国特种经营公司 | 口腔护理组合物 |
| BR112021024310A2 (pt) | 2019-06-05 | 2022-02-15 | Univ Emory | Peptidomiméticos para o tratamento de infecções por coronavírus e picornavírus |
| WO2021205296A1 (en) | 2020-04-05 | 2021-10-14 | Pfizer Inc. | Method of treating covid-19 |
| AU2021254045A1 (en) * | 2020-04-10 | 2022-10-13 | Cocrystal Pharma, Inc. | Inhibitors of norovirus and coronavirus replication |
| US11124497B1 (en) * | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| BR112022021381A2 (pt) * | 2020-04-23 | 2022-12-06 | Purdue Research Foundation | Compostos para o tratamento de sars |
| BR112021023814A2 (pt) * | 2020-06-09 | 2022-12-20 | Pardes Biosciences Inc | Inibidores de proteases de cisteína e métodos de uso das mesmas |
| MX2023001756A (es) * | 2020-08-13 | 2023-05-04 | Enanta Pharm Inc | Peptidos funcionalizados como agentes antivirales. |
| US11351149B2 (en) * | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| WO2022256434A1 (en) | 2021-06-02 | 2022-12-08 | ACEA Therapeutics, Inc. | Protease inhibitors as antivirals |
-
2022
- 2022-06-01 WO PCT/US2022/031815 patent/WO2022256434A1/en not_active Ceased
- 2022-06-01 CA CA3220847A patent/CA3220847A1/en active Pending
- 2022-06-01 JP JP2023574150A patent/JP2024522990A/ja active Pending
- 2022-06-01 TW TW111120433A patent/TW202313567A/zh unknown
- 2022-06-01 US US17/830,185 patent/US11753373B2/en active Active
- 2022-06-01 BR BR112023025358A patent/BR112023025358A2/pt unknown
- 2022-06-01 IL IL308694A patent/IL308694A/en unknown
- 2022-06-01 EP EP22735725.8A patent/EP4347034A1/en active Pending
- 2022-06-01 KR KR1020237045446A patent/KR20240057384A/ko active Pending
- 2022-06-01 MX MX2023014307A patent/MX2023014307A/es unknown
- 2022-06-01 AU AU2022283816A patent/AU2022283816A1/en active Pending
-
2023
- 2023-06-15 US US18/210,555 patent/US11987554B2/en active Active
-
2024
- 2024-04-22 US US18/642,453 patent/US20250122153A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522990A5 (https=) | ||
| JP2818820B2 (ja) | 抗炎症剤としての３−アリール−２−イソオキサゾリン類 | |
| CN108368040B (zh) | 二芳基单环β-内酰胺化合物及其用于治疗细菌感染的方法 | |
| RU2306309C2 (ru) | Производное 8-азапростагландина, фармацевтическая композиция, агент для профилактики заболеваний | |
| ES2278454T3 (es) | Compuestos de imidazol sustituido que tienen actividad inhibitoria de citoquinas. | |
| AU2009330194B2 (en) | C5aR antagonists | |
| JP2021534124A5 (https=) | ||
| TW201431865A (zh) | 硼酸衍生物及其治療用途 | |
| ES2662894T3 (es) | Derivados de 2H-indazol antibacterianos | |
| CA2672373A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| JP2010265292A (ja) | ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法 | |
| KR101346527B1 (ko) | 아민 화합물 및 그 의약 용도 | |
| JP2023533855A5 (https=) | ||
| WO2013083975A2 (en) | Novel pyrrole derivatives | |
| JP2002526527A (ja) | タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド | |
| EP0652884B1 (en) | Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity | |
| JP2022048391A (ja) | インフルエンザを処置するためのオルソミクソウイルス複製の阻害剤としての１０－（ジ（フェニル）メチル）－４－ヒドロキシ－８，９，９ａ，１０－テトラヒドロ－７Ｈ－ピロロ［１’，２’：４，５］ピラジノ［１，２－ｂ］ピリダジン－３，５－ジオン誘導体および関連化合物 | |
| RU2627361C2 (ru) | Биарил- или гетероциклические биарилзамещенные производные циклогексена в качестве ингибиторов сетр | |
| JP6790256B2 (ja) | フェノチアジン誘導体及びその使用方法 | |
| TW202604893A (zh) | 經取代吡啶及苯基化合物 | |
| TH2101006585A (th) | ตัวควบคุมพาธเวย์การตอบสนองความเค้นรวม | |
| HK40033744B (zh) | 作为正粘病毒复制抑制剂用於治疗流感的化合物 | |
| ZA200102651B (en) | Naphthalenecarboxamides as tachykinin receptor antagonists. | |
| AU2014200986A1 (en) | 4-hydroxybutyric acid analogs |